These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 28475813)

  • 1. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
    Mak LY; Ng SC; Wong IOL; Li MKK; Lo FH; Wong MTL; Leung CM; Tsang SWC; Chan KH; Sze SF; Shan EHS; Lam BCY; Hui AJ; Hung IFN; Leung WK
    J Gastroenterol Hepatol; 2018 Jan; 33(1):141-149. PubMed ID: 28475813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection-related hospitalizations in the first year after inflammatory bowel disease diagnosis.
    Ko MK; Ng SC; Mak LY; Li MK; Lo FH; Ng CK; Lao WC; Tsang S; Chan KH; Hui YT; Shan EH; Loo CK; Hui AJ; To WP; Hung IF; Leung WK
    J Dig Dis; 2016 Sep; 17(9):610-617. PubMed ID: 27533786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study.
    Burisch J; Vardi H; Schwartz D; Friger M; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Lakatos L; Lakatos PL; D'Incà R; Sartini A; Valpiani D; Giannotta M; Arebi N; Duricova D; Bortlik M; Chetcuti Zammit S; Ellul P; Pedersen N; Kjeldsen J; Midjord JMM; Nielsen KR; Winther Andersen K; Andersen V; Katsanos KH; Christodoulou DK; Domislovic V; Krznaric Z; Sebastian S; Oksanen P; Collin P; Barros L; Magro F; Salupere R; Kievit HAL; Goldis A; Kaimakliotis IP; Dahlerup JF; Eriksson C; Halfvarson J; Fernandez A; Hernandez V; Turcan S; Belousova E; Langholz E; Munkholm P; Odes S;
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):454-464. PubMed ID: 32061322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Care Cost Analysis in a Population-based Inception Cohort of Inflammatory Bowel Disease Patients in the First Year of Diagnosis.
    Niewiadomski O; Studd C; Hair C; Wilson J; McNeill J; Knight R; Prewett E; Dabkowski P; Dowling D; Alexander S; Allen B; Tacey M; Connell W; Desmond P; Bell S
    J Crohns Colitis; 2015 Nov; 9(11):988-96. PubMed ID: 26129692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
    Park KT; Ehrlich OG; Allen JI; Meadows P; Szigethy EM; Henrichsen K; Kim SC; Lawton RC; Murphy SM; Regueiro M; Rubin DT; Engel-Nitz NM; Heller CA
    Inflamm Bowel Dis; 2020 Jan; 26(1):1-10. PubMed ID: 31112238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study.
    Burisch J; Vardi H; Pedersen N; Brinar M; Cukovic-Cavka S; Kaimakliotis I; Duricova D; Bortlik M; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Krabbe S; Andersen V; Dahlerup JF; Kjeldsen J; Salupere R; Olsen J; Nielsen KR; Manninen P; Collin P; Katsanos KH; Tsianos EV; Ladefoged K; Lakatos L; Bailey Y; OʼMorain C; Schwartz D; Lupinacci G; De Padova A; Jonaitis L; Kupcinskas L; Turcan S; Barros L; Magro F; Lazar D; Goldis A; Nikulina I; Belousova E; Fernandez A; Pineda JR; Almer S; Halfvarson J; Tsai HH; Sebastian S; Friger M; Greenberg D; Lakatos PL; Langholz E; Odes S; Munkholm P;
    Inflamm Bowel Dis; 2015 Jan; 21(1):121-31. PubMed ID: 25437816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases.
    Limsrivilai J; Stidham RW; Govani SM; Waljee AK; Huang W; Higgins PD
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):385-392.e2. PubMed ID: 27645518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mental Health Costs of Inflammatory Bowel Diseases.
    Szigethy E; Murphy SM; Ehrlich OG; Engel-Nitz NM; Heller CA; Henrichsen K; Lawton R; Meadows P; Allen JI
    Inflamm Bowel Dis; 2021 Jan; 27(1):40-48. PubMed ID: 32095835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of inflammatory bowel disease in Germany.
    Stark R; König HH; Leidl R
    Pharmacoeconomics; 2006; 24(8):797-814. PubMed ID: 16898849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Direct Healthcare Costs before and after the Diagnosis of Inflammatory Bowel Disease: A Nationwide Population-Based Study.
    Lee J; Im JP; Han K; Kim J; Lee HJ; Chun J; Kim JS
    Gut Liver; 2020 Jan; 14(1):89-99. PubMed ID: 31158951
    [No Abstract]   [Full Text] [Related]  

  • 12. The Evolution of Health Care Utilisation and Costs for Inflammatory Bowel Disease Over Ten Years.
    Pillai N; Dusheiko M; Maillard MH; Rogler G; Brüngger B; Bähler C; Pittet VEH;
    J Crohns Colitis; 2019 May; 13(6):744-754. PubMed ID: 30916775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study.
    Yu Q; Zhu C; Feng S; Xu L; Hu S; Chen H; Chen H; Yao S; Wang X; Chen Y
    J Med Internet Res; 2021 Jan; 23(1):e20629. PubMed ID: 33399540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation.
    Odes S; Vardi H; Friger M; Wolters F; Russel MG; Riis L; Munkholm P; Politi P; Tsianos E; Clofent J; Vermeire S; Monteiro E; Mouzas I; Fornaciari G; Sijbrandij J; Limonard C; Van Zeijl G; O'morain C; Moum B; Vatn M; Stockbrugger R;
    Gastroenterology; 2006 Sep; 131(3):719-28. PubMed ID: 16952541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct and Indirect Costs of Inflammatory Bowel Disease: Ten Years of Follow-up in a Danish Population-based Inception Cohort.
    Lo B; Vind I; Vester-Andersen MK; Bendtsen F; Burisch J
    J Crohns Colitis; 2020 Jan; 14(1):53-63. PubMed ID: 31076743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014.
    Bähler C; Vavricka SR; Schoepfer AM; Brüngger B; Reich O
    BMC Gastroenterol; 2017 Dec; 17(1):138. PubMed ID: 29197335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Safety, Medical Resource Utilization, and Treatment Costs by Drug Class for Management of Inflammatory Bowel Disease in the United States Based on Insurance Claims Data.
    Long GH; Tatro AR; Oh YS; Reddy SR; Ananthakrishnan AN
    Adv Ther; 2019 Nov; 36(11):3079-3095. PubMed ID: 31562607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phenome-Wide Analysis of Healthcare Costs Associated with Inflammatory Bowel Diseases.
    Cai W; Cagan A; He Z; Ananthakrishnan AN
    Dig Dis Sci; 2021 Mar; 66(3):760-767. PubMed ID: 32436120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study.
    Murthy SK; James PD; Antonova L; Chalifoux M; Tanuseputro P
    PLoS One; 2017; 12(5):e0177211. PubMed ID: 28498877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.